16th Jul 2009 16:31
RNS Number : 8239V
Fulcrum Pharma PLC
16 July 2009
FULCRUM PHARMA PLC
("the Company")
Directors' Dealings and Issue of Options
The Company was informed on 16 July 2009 that on 16 July 2009 certain Directors of the Company bought ordinary shares of 1 penny each in the Company, as detailed below at a price of 3.2705 pence per share.
|
|
Shares purchased
|
Shareholding after acquisition
|
Percentage of Issued Share Capital
|
|
Grahame Cook (Non-executive Chairman)
|
1,000,000
|
1,600,000
|
0.90%
|
|
Frank Armstrong (CEO)
|
250,000
|
850,000
|
0.48%
|
|
Barry Knight (CFO)
|
100,000
|
100,000
|
0.06%
|
The Company also announces that on 13 July 2009 the following options were issued to Barry Knight, CFO of the Company.
|
|
No of options
|
Option price (pence)
|
Exercise Period
|
|
Barry Knight (CFO)
|
800,000
|
2.125
|
10 years
|
|
Barry Knight (CFO)
|
2,300,000
|
6
|
10 years
|
|
Barry Knight (CFO)
|
2,300,000
|
12
|
10 years
|
Enquiries:
Fulcrum Pharma plc
Barry Knight 01442 283 618
Seymour Pierce Limited
Jonathan Wright / Christopher Wren 0207 107 8047
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
FUL.L